CTI BioPharma Corp (CTIC) Down 1.03% in Premarket Trading

Thursday, August 18, 2022 09:20 AM | InvestorsObserver Analysts

Mentioned in this article

CTI BioPharma Corp (CTIC) is down Thursday morning, with the stock falling -1.03% in pre-market trading to 5.77. CTIC's short-term technical score of 93 indicates that the stock has traded more bullishly over the last month than 93% of stocks on the market. In the Biotechnology industry, which ranks 117 out of 146 industries, CTIC ranks higher than 93% of stocks. CTI BioPharma Corp has fallen 6.72% over the past month, closing at $6.13 on July 21. During this period of time, the stock fell as low as $5.41 and as high as $7.80. CTIC has an average analyst recommendation of Strong Buy. The company has an average price target of $9.58.

CTIC has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on CTIC!
See Full CTIC Report
CTI BioPharma Corp has a Long-Term Technical rank of 89. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 11% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, CTIC ranks better than 83% of stocks.

Important Dates for Investors in CTIC:

-CTI BioPharma Corp is set to release earnings on 11/6/2022. Over the last 12 months, the company has reported EPS of $-1.23. -We do not have a set dividend date for CTI BioPharma Corp at this time. Click Here To Get The Full Report on CTI BioPharma Corp (CTIC)

Share this article:

Related Articles